Trial Profile
A Randomized Placebo-Controlled Double-Blind Clinical Trial to Assess the Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 01 Jan 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 03 Oct 2009 New trial record